Adithya Cattamanchi - Concepedia

Author

Adithya Cattamanchi

University of California, San Francisco ORCID

Also Known As

A Cattamanchi, A. Cattamanchi, ADITHYA CATTAMANCHI, Adithya Cattamanchi, Adithya Cattamanchi (121837), Cattamanchi Adithya, Cattamanchi, Adithya, Elisa Romani-Huacani, Goodman, Carol D., Grant Theron

387

Publications

12K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Makerere University San Francisco General Hospital Johns Hopkins University Mulago Hospital

About

Adithya Cattamanchi is an author at University of California, San Francisco specializing in medicine, tuberculosis, and tuberculosis prevention.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	2.7K
2	Public Health	12	12	464
3	Health Sciences	4	4	1.5K
4	Nursing	3	3	66
5	Engineering	2	2	129

Adithya Cattamanchi

146

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Payam Nahid, Susan E. Dorman, Narges Alipanah, Clinical Infectious Diseases Tuberculosis TreatmentTuberculosis PreventionPediatric Lung DiseasePrevention/infectious Diseases SocietyDiagnostics	2016	1.4K
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari Mase, Giovanni Battista Migliori, American Journal of Respiratory and Critical Care Medicine	2019	430
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Payam Nahid, Susan E. Dorman, Narges Alipanah, Clinical Infectious Diseases	2016	310
Test Variability of the QuantiFERON-TB Gold In-Tube Assay in Clinical Practice John Metcalfe, Adithya Cattamanchi, Charles E. McCulloch, American Journal of Respiratory and Critical Care Medicine	2013	183
DISTINGUISHING RECRUDESCENCE FROM REINFECTION IN A LONGITUDINAL ANTIMALARIAL DRUG EFFICACY STUDY: COMPARISON OF RESULTS BASED ON GENOTYPING OF MSP-1, MSP-2, AND GLURP Adithya Cattamanchi, Daniel Kyabayinze, Alan Hubbard, American Journal of Tropical Medicine and Hygiene Lifespan ExtensionDisease SusceptibilityPlasmodium Falciparum GenesMedicineGenetics	2003	170
Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study Christina Yoon, Fred C. Semitala, Elly Atuhumuza, The Lancet Infectious Diseases Pulmonary TuberculosisPoint-of-care TestingTreatment And PreventionDiagnostic TestTuberculosis Prevention	2017	138
Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial Grant Dorsey, Denise Njama, Moses R. Kamya, The Lancet Longitudinal Randomised TrialMedicineAntiparasitic AgentMalariaUncomplicated Malaria	2002	137
Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach Irene Ayakaka, Sara Ackerman, Joseph Ggita, Implementation Science	2017	131
Clinical Characteristics and Treatment Outcomes of Patients with Isoniazid‐Monoresistant Tuberculosis Adithya Cattamanchi, Raymund Dantes, John Metcalfe, Clinical Infectious Diseases	2008	112
Transcriptional Adaptation of Drug-tolerant<i>Mycobacterium tuberculosis</i>During Treatment of Human Tuberculosis Nicholas D. Walter, Gregory Dolganov, Benjamin J. Garcia, The Journal of Infectious Diseases	2015	110

Page 1